Northland Capmk Comments on Astera Labs FY2026 Earnings

Astera Labs, Inc. (NASDAQ:ALAB) – Investment analysts at Northland Capmk issued their FY2026 earnings estimates for shares of Astera Labs in a research note issued to investors on Thursday, January 2nd. Northland Capmk analyst G. Richard anticipates that the company will post earnings per share of $0.71 for the year. Northland Capmk currently has a “Hold” rating on the stock. The consensus estimate for Astera Labs’ current full-year earnings is ($0.45) per share.

Other equities analysts also recently issued research reports about the company. Northland Securities downgraded Astera Labs from an “outperform” rating to a “market perform” rating and increased their price objective for the stock from $100.00 to $120.00 in a report on Thursday. Craig Hallum lifted their target price on Astera Labs from $75.00 to $105.00 and gave the stock a “buy” rating in a report on Tuesday, November 5th. Needham & Company LLC restated a “buy” rating and set a $65.00 price objective on shares of Astera Labs in a research report on Wednesday, October 9th. Barclays lifted their target price on shares of Astera Labs from $70.00 to $87.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 5th. Finally, Stifel Nicolaus raised their price target on Astera Labs from $80.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday, November 5th. Two research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to data from MarketBeat.com, Astera Labs presently has a consensus rating of “Moderate Buy” and a consensus price target of $101.58.

Astera Labs Stock Performance

ALAB stock opened at $140.93 on Monday. Astera Labs has a 12-month low of $36.22 and a 12-month high of $147.36. The firm’s 50-day moving average price is $109.63 and its two-hundred day moving average price is $71.62.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Monday, November 4th. The company reported $0.23 earnings per share for the quarter, topping analysts’ consensus estimates of $0.17 by $0.06. The business had revenue of $113.10 million for the quarter, compared to analyst estimates of $97.50 million. Astera Labs had a negative return on equity of 15.57% and a negative net margin of 30.69%. The firm’s quarterly revenue was up 47.1% compared to the same quarter last year.

Insider Buying and Selling

In other Astera Labs news, Director Manuel Alba sold 11,000 shares of the firm’s stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $117.50, for a total transaction of $1,292,500.00. Following the completion of the transaction, the director now owns 456,863 shares in the company, valued at $53,681,402.50. This trade represents a 2.35 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CFO Michael Truett Tate sold 16,000 shares of the company’s stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $117.84, for a total value of $1,885,440.00. Following the sale, the chief financial officer now directly owns 1,412,888 shares in the company, valued at $166,494,721.92. This trade represents a 1.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 1,978,119 shares of company stock valued at $186,618,509.

Institutional Investors Weigh In On Astera Labs

Hedge funds have recently bought and sold shares of the business. Bank of New York Mellon Corp purchased a new stake in shares of Astera Labs during the 2nd quarter valued at about $8,361,000. Rhumbline Advisers bought a new stake in shares of Astera Labs in the 2nd quarter valued at approximately $1,009,000. Victory Capital Management Inc. purchased a new position in shares of Astera Labs in the 2nd quarter worth approximately $815,000. Ground Swell Capital LLC bought a new position in shares of Astera Labs during the 2nd quarter valued at approximately $524,000. Finally, Massachusetts Financial Services Co. MA raised its holdings in Astera Labs by 2.6% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 91,408 shares of the company’s stock valued at $5,531,000 after buying an additional 2,343 shares during the period. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.